The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies - Bajou,K.; Masson,V.; Gerard,R.D. (J Cell Biol, 2001)